EP2635282
Samsetningar til að meðhöndla beinmergstrefjun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.11.2011EP published:
28.9.2022EP application number:
11838957.6
EP translation filed:
24.10.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
6.11.2031Expiry date:
6.11.2026Next due date:
30.11.2026
Title in English:
COMPOSITIONS FOR TREATING MYELOFIBROSISLanguage of the patent:
English
Timeline
Today
7.11.2011EP application
28.9.2022EP Publication
24.10.2022Translation submitted
15.11.2022Registration published
6.11.2026Expires
Owner
Name:
Impact Biomedicines, Inc.Address:
86 Morris Avenue, Summit, New Jersey 07901, US
Inventor
Name:
JAYAN, ArvindAddress:
La Jolla CA 92037, US
Name:
CACACE, JaniceAddress:
Miami FL 33137, US
Name:
TEFFERI, AyalewAddress:
Rochester, MN 55905, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
410924 PDate:
7.11.2010Country:
US
Classification
Categories:
A61K 31/506, A61K 9/48, A61P 7/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 8.11.2022
Expires: 6.11.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.11.2023
Expires: 6.11.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.10.2024
Expires: 6.11.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.11.2025
Expires: 6.11.2026
Payer: Árnason Faktor ehf.